Changes in rat cerebral blood volume due to modulation of the 5-HT1A receptor measured with susceptibility enhanced contrast MRI

Brain blood volume changes in the rat in response to 5-HT(1A) agonist and antagonist administration were measured using susceptibility contrast enhanced magnetic resonance imaging (MRI). Administration of the 5-HT(1A) agonist 8-OH-DPAT resulted in decreases in fractional brain blood volumes. Administration of the 5-HT(1A) antagonist WAY-100635 following a dose of 8-OH-DPAT resulted in increases in fractional blood volumes greatest in hippocampus and cortex and smallest in thalamus and caudate-putamen. The magnitude of the regional increases in blood volumes paralleled the distribution of 5-HT(1A) receptors in the rat brain. Administration of WAY-100635 alone resulted in decreases in cortical blood volume and increases in cerebellar blood volume.

[1]  J C Gore,et al.  Physiological basis for BOLD MR signal changes due to neuronal stimulation: Separation of blood volume and magnetic susceptibility effects , 1998, Magnetic resonance in medicine.

[2]  B. Jacobs,et al.  WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. , 1996, The Journal of pharmacology and experimental therapeutics.

[3]  Allan Fletcher,et al.  Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist , 1995, Behavioural Brain Research.

[4]  C. Montigny,et al.  Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[5]  J C Gore,et al.  Physiologic basis for BOLD MR signal changes due to hypoxia/hyperoxia: Separation of blood volume and magnetic susceptibility effects , 1997, Magnetic resonance in medicine.

[6]  G. Martin.  Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. , 1994, Pharmacology & therapeutics.

[7]  G. Bonvento,et al.  Effects of Electrical Stimulation of the Dorsal Raphe Nucleus on Local Cerebral Blood Flow in the Rat , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  B. Jacobs,et al.  Activity of brain serotonergic neurons in the behaving animal. , 1991, Pharmacological reviews.

[9]  F. Graeff,et al.  Role of 5-HT in stress, anxiety, and depression , 1996, Pharmacology Biochemistry and Behavior.

[10]  Y. Nishimura.  Characterization of 5‐hydroxytryptamine receptors mediating contractions in basilar arteries from stroke‐prone spontaneously hypertensive rats , 1996, British journal of pharmacology.

[11]  B. Rosen,et al.  Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation , 1998, Magnetic resonance in medicine.

[12]  E. Mackenzie,et al.  Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. , 1989, The Journal of pharmacology and experimental therapeutics.

[13]  John Sharkey,et al.  Cerebrovascular and functional consequences of 5-HT1A receptor activation , 1991, Brain Research.

[14]  W. Koek,et al.  Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. , 1996, European journal of pharmacology.

[15]  P. Pietrini,et al.  Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats , 1995, Brain Research.

[16]  D. Murphy,et al.  Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. , 1998, The Journal of clinical psychiatry.

[17]  M. Hamon,et al.  Central serotonin1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain , 1991, Neurochemistry International.

[18]  Pharmacokinetics of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OHDPAT) in the rat after intravenous and oral administration. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  G. Bishop,et al.  The physiological effects of serotonin are mediated by the 5HT1A receptor in the cat's cerebellar cortex , 1992, Brain Research.

[20]  A. Schleicher,et al.  Effect of the 5-HT1A receptor agonist ipsapirone on the local cerebral glucose utilization of the rat hippocampus , 1987, Brain Research.

[21]  G. Aghajanian,et al.  Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. , 1978, Science.

[22]  G. Goodwin,et al.  Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine, agonists , 1988, Neuroscience.

[23]  B. Lerer,et al.  5-HT-1A receptor-mediated effects of antidepressants , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.